SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection

A Contract Award Notice
by WESTERN HEALTH & SOCIAL CARE TRUST

Source: Find a Tender
Type: Contract ()
Duration: not specified
Value: £5M

Sector: MISCELLANEOUS
Published: 08 Dec 2025
Delivery: not specified
Deadline: n/a

Related Terms

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

Western Health & Social Care Trust Londonderry

1 supplier

Novartis Pharmaceuticals London

Description

Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 30/11/2028.

Award Detail

1	Novartis Pharmaceuticals (London) SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection Reference: 1 Value: £4,638,166

CPV Codes

None found

Legal Justification

Section 41 of the PA2023, permits a direct award in specific cases. Schedule 5 of the PA2023 sets out justifications for direct award - this particular supplier having intellectual property rights or other exclusive rights, only this supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works